Furthermore, Oncotype DX® Prostate Cancer, a commercially available gene expression signature, includes SFRP4 as one of its 17 genes, and has been associated with clinical recurrence of prostate cancer after prostatectomy11. The gene discussed is SFRP4; the disease is prostate cancer.